Epigenomics' 2009 Revenues Rise 65 Percent

The German molecular diagnostics firm brought in revenues of €4.3 million ($5.8 million) for the year as it launched its first test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.